{"id":"W4405374998","doi":"10.1016/j.iotech.2024.100749","title":"120MO Inupadenant combined with chemotherapy in patients with non-squamous NSCLC progressing on or after immune checkpoint inhibitor therapy: Results from dose-finding part of the A2A-005 trial","year":2024,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"William Osler Health System; Brampton Civic Hospital","funders":"","keywords":"Medicine; Oncology; Chemotherapy; Internal medicine; Immune checkpoint; Immune system; Immunotherapy; Immunology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007583913,0.0006755997,0.001151088,0.0002104823,0.0001886227,0.0008164323,0.0004011828,0.000605406,0.002419481],"category_scores_gemma":[0.000392437,0.0002027601,0.001189288,0.0002542895,0.0003549605,0.0005108906,0.0002419134,0.001543927,0.0004133062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006022121,"about_ca_system_score_gemma":0.000619167,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006488094,"about_ca_topic_score_gemma":0.001741382,"domain_scores_codex":[0.9997457,0.0001282542,0.00001457192,0.00004194145,0.00002182684,0.00004779374],"domain_scores_gemma":[0.9997855,0.00003390166,0.00004879298,0.00001874641,0.00001196891,0.0001012677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8052304,0.01853216,0.01460929,0.001446837,0.003185059,0.0001805383,0.0002327395,0.002281096,0.02447647,0.0003520979,0.003570909,0.1259024],"study_design_scores_gemma":[0.5381893,0.3998522,0.04765298,0.0001775138,0.002119556,0.0002909574,0.0001210501,0.001731207,0.003913054,0.0003934625,0.005524373,0.00003436293],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948932,0.002276967,0.0001247022,0.0002302099,0.00007409871,0.0004233125,0.0004304725,0.00003374404,0.001513377],"genre_scores_gemma":[0.9942219,0.001634793,0.0002732357,0.0004550661,0.0001001813,0.0004471781,0.001270436,0.00001079554,0.001586348],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002419481,"threshold_uncertainty_score":0.008093953,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01290091525342313,"score_gpt":0.2756339601567856,"score_spread":0.2627330449033625,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}